Gene Query: TMEM38A

Dataset Description Geneva Score
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 48.82
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 43.6
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 33.53
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 33.53
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 32.6
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 32.1
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 31.58
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 31.17
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 26.5
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 25.94
RNA-seq of tumor cells following angiopellosis extravasation 17.02
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 16.73
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 16.19
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 16.11
Transcriptome of human white and brown adipose tissue biopsies 15.88
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 15.45
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 14.85
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 13.17
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 12.06
Expression charcaterization of an internal protocol developed to differentiate RPE cells 11.92
RNA-seq data from human lymphoma cell lines 11.77
ChIP-seq and RNA-seq from human lymphoma cell lines 11.77
11.37
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 11.05
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 10.95
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 10.82
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 10.73
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 10.08
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 9.95
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 9.62
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.08
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.87
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.71
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 8.53
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 8.52
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 8.52
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 7.43
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 7.4
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 7.11
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 6.94
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 6.54
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 6.26
RNA-seq of YB5 cells treated with Proscillaridin A 6.08
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 5.98
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 5.93
RNA-sequencing of healthy human skeletal myocytes 5.75
Dtx3L and Androgen Signaling in Prostate Cancer 5.65
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 5.42
Widespread regulated alternative splicing of single codons accelerates proteome evolution 5.28
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 5.25
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 5.12
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 5.11
hnRNP C is a key regulator of protein synthesis in mitosis 5.01
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 4.99
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 4.91
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 4.83
circRNA profile in hypopharyngeal cancer 4.71
The Human Testis Cell Atlas via Single-cell RNA-seq 4.69
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 4.69
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 4.65
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 4.61
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 4.47
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.42
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.39
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 4.38
The role of FAM46C in myeloma cells [sequencing] 4.33
The role of FAM46C in myeloma cells 4.33
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 4.27
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.19
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 3.99
CUREfast: Accelerating research with families 3.98
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 3.96
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 3.87
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.86
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.83
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 3.83
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.76
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.76
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 3.76
Effect of Hotair overexpression in human breast cancer cell lines 3.7
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 3.65
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 3.65
Nutritional control of protein translation 3.64
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.53
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 3.46
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 3.45
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 3.45
Seletive inhibition of CDK9 in DLBCL cell lines 3.39
Global epigenomic reconfiguration during mammalian brain development 3.38
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.37
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 3.37
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 3.22
Ro60-knockout cells 3.2
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 3.13
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 3.13
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 3.1
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 3.1
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 3.09
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 3.09
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 3.04
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.99
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 2.95
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 2.93
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.93
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.93
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.85
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 2.85
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 2.85
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 2.79
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 2.78
BET bromodomain inhibition 2.78
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 2.77
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 2.77
RNA-seq analysis and shRNA screen of breast cancer 2.72
RNA-seq analysis of breast cancer 2.72
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 2.65
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 2.6
Gene expression profiling of human and murine in vitro muscle differentiation 2.51
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.5
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 2.49
Identification of expressed and conserved human non-coding RNAs 2.46
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.43
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.4
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 2.36
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.35
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 2.35
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.32
Effect of PRDM11 depletion in U2932 cells 2.3
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 2.29
BAF controls genome accessibility 2.28
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 2.24
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.24
HNRNPL and its RNA Targets in Prostate Cancer 2.24
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 2.24
Global analysis of alternative splicing regulated by RBM10 2.22
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 2.22
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 2.22
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 2.22
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 2.17
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 2.13
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 2.11
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 2.05
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 2.05
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 2.05
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 2.03
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 2.0
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 2.0
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.0
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 1.98
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 1.94
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 1.94
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 1.92
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.87
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 1.85
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 1.85
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.8
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 1.8
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.8
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.8
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.8
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.8
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.78
Accurate annotation of human protein-coding small open reading frames 1.76
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.74
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.72
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 1.7
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.7
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 1.7
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 1.68
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.66
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 1.64
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 1.64
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 1.63
The evolution of N6-methyladenosine in primates 1.63
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.6
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.6
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 1.59
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.57
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.57
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.57
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.56
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.54
IDH3a KO RNA-seq 1.53
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.52
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.52
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 1.47
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.44
Fusion discovery in breast cancer cell line 1.44
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 1.42
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 1.39
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.39
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.39
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.37
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 1.37
Landscape of H3K4me3 in human CD19 cells 1.37
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  1.36
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.35
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.35
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 1.34
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 1.34
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 1.34
Comparing gene expression in iPSC derived RPE from control and AMD donors 1.32
Gene expression signatures of innate lymphoid cells from human blood 1.32
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.32
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 1.32
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.31
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 1.31
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 1.31
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 1.3
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 1.3
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.3
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 1.29
RNA-seq of cancer cell lines treated with T-025 1.27
EP400 is required for Max and MCPyV mediated gene activation 1.27
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.24
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.24
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.23
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.22
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.22
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 1.22
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 1.22
Lysine benzoylation is a novel histone mark [RNA-seq] 1.21
Lysine benzoylation is a novel histone mark 1.21
Fbxo32 mediated gene expression program underlies EMT and metastasis 1.2
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.2
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.2
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.19
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.18
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 1.17
Repurposing of promoters and enhancers during mammalian evolution 1.17
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 1.16
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.16
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 1.16
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.15
Chromatin landscape of human visceral and subcutaneous adipocytes 1.15
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.14
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.14
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 1.14
KSDM1b Role in Ewing Sarcoma 1.14
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.13
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.12
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 1.12
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.11
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 1.1
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.09
Co-regulation of splicing by Rbfox1 and hnRNP M 1.09
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 1.09
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 1.09
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 1.08
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.06
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 1.06
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 1.06
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 1.05
Total RNA sequencing of WT intestinal orgaonids. 1.05
RNA-seq differential expression studies: more sequence, or more replication? 1.04
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 1.04
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 1.04
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.03
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 1.03
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 1.03
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 1.02
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 1.02
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 1.02
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 1.02
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.01
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 1.01
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 1.0
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 1.0
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.0
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.0
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 0.99
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 0.99
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 0.98
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 0.98
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 0.98
Gene expression analysis of immortalized human liver progenitor-like cells in culture 0.97
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 0.96
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 0.96
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 0.96
Paxillin regulates genomic networks in prostate cancer [PC3] 0.96
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.95
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.94
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 0.93
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 0.93
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 0.92
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.92
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.92
MYC dependent mRNA translation shapes gene expression and cell biology 0.92
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.91
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.91
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.91
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.91
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 0.91
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 0.91
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 0.9
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.89
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.89
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.88
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.88
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 0.88
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 0.88
Regulation of hypoxia-inducible factor activity by ZMYND8 0.88
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 0.87
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.87
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.87
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 0.86
The landscape of alternative splicing in aggressive prostate cancers 0.86
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 0.85
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.85
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.85
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.85
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.84
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 0.84
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 0.83
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 0.83
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 0.83
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 0.83
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 0.82
Discovering human diabetes-risk gene function with genetics and physiological assays 0.82
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.82
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.82
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 0.81
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 0.81
SETBP1-WT and SETBP1-G870S epigenetic landscapes 0.81
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.8
A transcriptome-wide divergence in protein translation scales with LIN28B expression 0.8
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 0.8
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 0.8
Statins modulate endothelial transcriptional profile by inhibiting EZH2 0.77
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.77
Landscape and variation of RNA secondary structure across the human transcriptome 0.76
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 0.75
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.74
Noncoding regions are the main source of targetable tumor-specific antigens 0.74
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 0.73
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.72
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.72
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 0.72
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.71
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.7
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 0.7
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.69
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.69
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 0.68
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 0.68
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 0.68
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 0.68
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.68
Gene expression profile in breast cancer cells 0.68
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.68
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.68
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.68
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.67
HNF1A deficiency impairs β-cell fate, granule maturation and function 0.67
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 0.67
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 0.66
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 0.66
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.66
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.66
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.65
The cohesin release factor WAPL restricts chromatin loop extension. 0.65
Modeling Human Cancer-induced Cachexia (Human) 0.64
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 0.63
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 0.63
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 0.63
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.63
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.63
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.62
RNA-seq analysis of control and Myc-induced U2OS cells 0.62
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.62
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.58
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.58
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 0.58
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 0.58
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 0.58
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.57
Be1 and Be2 B cells are transcriptionally distinct 0.57
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.57
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 0.55
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.54
Gene expression changes due to PARP knockdown in human cells 0.54
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.53
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 0.53
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 0.53
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.53
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.53
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.53
RNA sequencing of human pancreatic cancer cell lines 0.52
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.52
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.52
Effect of nuclear IL-33 on gene expression 0.5
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.5
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 0.5
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 0.5
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.49
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 0.48
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.47
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 0.47
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.46
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.45
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.44
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.44
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 0.44
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 0.44
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.43
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.43
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.43
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.43
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.41
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.41
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.4
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.39
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.39
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 0.39
Dynamic reorganization of nuclear architecture during human cardiogenesis 0.39
Characterization of human ILC2 subsets 0.39
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 0.39
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.38
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.37
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.36
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.35
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.35
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.35
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.35
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.35
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 0.35
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 0.35
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.35
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.35
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.34
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.34
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.34
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.34
Modulation of nonsense-mediated decay by rapamycin 0.33
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.33
Effect of PBK knockdown on C4-2 cell transcriptome 0.32
MRTF activates TEAD-YAP target gene expression 0.32
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 0.31
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.3
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 0.29
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.29
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.29
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.29
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.28
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 0.27
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.27
Transcriptomic analysis of frontal fibrosing alopecia 0.26
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.26
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.26
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 0.26
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.25
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.25
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.25
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.24
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.22
Dilated cardiomyopathy vs Myocarditis 0.21
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.2
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.2
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.2
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.18
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.17
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.16
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 0.16
Tyrosine Kinase Inhibitor Cardiotoxicity 0.16
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.16
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.16
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.16
Epigenomic conservation of transposable element silencing 0.15
Epigenomic conservation of transposable element silencing [RNA-seq] 0.15
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.15
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.15
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.14
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.13
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.13
Bone marrow derived human B cells [normal proB] 0.13
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.11
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.11
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.11
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.11
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.1
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.1
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.08
RNA-Seq of the corpus callosum from 12 individuals 0.08
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.08
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.06
The Glioma-Infiltrating T Cell Receptor Repertoire 0.05
RNA Sequencing of Human iPS derived Cardiomyocytes 0.05
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.05
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.05
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.05
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.04
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.04
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.03
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.02
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.02
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.02
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.02
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.01
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation